Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)

NCT03873038 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Dialysis
Kidney Failure, Chronic

Interventions

DRUG: MK-2060
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC